ClinicalTrials.Veeva

Menu

Innovative Endotracheal Tube Design Reduces Postoperative Laryngeal Injury (Triglotix®)

U

University Hospital of the Nuestra Señora de Candelaria

Status

Active, not recruiting

Conditions

Hoarseness
Laryngeal Injury
Bucking, Anesthesia Related
Cough
Sore-throat
Intubation Complication

Treatments

Device: Conventional endotracheal tube
Device: Triglotix®

Study type

Interventional

Funder types

Other

Identifiers

NCT06108271
Endotracheal tube Triglotix®

Details and patient eligibility

About

The goal of this randomized clinical trial is to compare two different orotracheal tubes in patients which require orotracheal intubation for general anesthesia. The main questions it aims to answer are:

  • To assess the presence of laryngeal injury
  • To evaluate the consequences in voice quality
  • To ask for the presence of symptoms as sore throat, hoarseness, and cough

Participants will be randomly assigned into two groups, one will use conventional endotracheal tube and the other will use Triglotix® endotracheal tube.

Full description

Endotracheal intubation is necessary in some patients undergoing surgical procedures and patients requiring mechanical ventilation in the intensive care unit. However, endotracheal intubation is associated with known complications. In post-surgical patients subjected to orotracheal intubation, the incidence of dysphagia, sore throat, hoarseness and cough is 43%,38%27%,32% respectivelly. These figures increase in cases of prolonged intubation, such as those in intensive care units, where reported rates are 76% for sore throat, 63% for hoarseness and 49% for dysphagia. No significant endotracheal tube design improvements have been developed over the past few decades addressing these issues.

The present study aims to compare the incidence of laryngeal injuries, and related symptoms as sore throat, hoarseness, swallowing problems, bucking and coughing between two defined sample populations: those utilizing a conventional endotracheal tube (ETT-C) and those employing the new Triglotix® endotracheal tube (ETT-T) in patients undergoing elective surgery requiring general anesthesia and mechanical ventilation.

Enrollment

68 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Elective perianal surgery requiring intubation for general anesthesia
  • Duration range 30-90 minutes

Exclusion criteria

  • Difficult airway
  • American Society of Anesthesiologists physical status (ASA) > III
  • Morbid obesity (body mass index >40 kg/m2)
  • Patients not suitable for outpatient surgery
  • Patients with history of previous neck surgery
  • Patients with history of dysphagia
  • Patients with comorbidities as diabetes and hypertension.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

68 participants in 2 patient groups

ETT-T
Experimental group
Description:
Endotracheal tube Triglotix®
Treatment:
Device: Triglotix®
ETT-C
Active Comparator group
Description:
Endotracheal tube conventional
Treatment:
Device: Conventional endotracheal tube

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems